MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

SL-START: A Multicentre Observational Study of Sublingual Apomorphine Titration and Usage Schemes in Routine Practice

J. Kassubek, P. Themann, H. Brigas, C. Maganete, G. Harrison-Jones, I. Pijuan Jiménez (Ulm, Germany)

Meeting: 2025 International Congress

Keywords: Apomorphine

Category: Parkinson’s Disease: Clinical Trials

Objective: A patient’s early experience with a new medication is critical to medication adherence and overall treatment outcomes. The SL-START study aims to characterize how sublingual apomorphine (SL-APO) is initiated, titrated, and used in routine clinical practice.

Background: Parkinson’s disease patients (PDP) experiencing motor fluctuations often suffer problems such as morning akinesia, delays in time-to-ON, and unpredictable OFF episodes with their levodopa regimen. APO is a potent, rapidly acting dopamine agonist with broad, ‘dopamine-like’ affinity at both D1-family and D2-family receptors. It requires individualized titration to optimal effectiveness while balancing tolerability. SL-APO film offers PDP an easy-to-administer, non-invasive, on-demand treatment option for a quick and reliable transition from OFF to ON.

Method: SL-START is a prospective, observational, 6-month study of SL-APO to be conducted at 12 sites across Germany. PDP (≥18y) experiencing intermittent OFF episodes not sufficiently controlled by oral antiparkinsonian medication are eligible if they have been prescribed SL-APO for the management of OFF episodes. Participants will be assessed at baseline, during titration, and after 3 and 6 months.

Results: The primary objective is to identify the different titration schemes, most frequent optimal dose after adjustment, median time to optimal dose and type of OFF episode used for dose-adjustment. Details of the SL-APO regimen, use of domperidone, and other PD medications will be documented. Clinician (CGI-C) and Patient (PGI-C) Global Impressions of Change and satisfaction with SL-APO will also be captured. Safety and tolerability will be assessed via adverse event reporting and the number of treatment discontinuations.

Conclusion: SL-START will inform on the factors of SL-APO titration that are important for patient retention and guide best practice for SL-APO titration strategies in real-world practice.

To cite this abstract in AMA style:

J. Kassubek, P. Themann, H. Brigas, C. Maganete, G. Harrison-Jones, I. Pijuan Jiménez. SL-START: A Multicentre Observational Study of Sublingual Apomorphine Titration and Usage Schemes in Routine Practice [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/sl-start-a-multicentre-observational-study-of-sublingual-apomorphine-titration-and-usage-schemes-in-routine-practice/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/sl-start-a-multicentre-observational-study-of-sublingual-apomorphine-titration-and-usage-schemes-in-routine-practice/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley